EnteroTarget ApS: Financial statements 2019
CVR: 39315769
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
EnteroTarget ApS (CVR 39315769) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -19,827 and a net result of DKK -15,465 compared with DKK -30,746 the year before. Equity in the 2019 report amounted to DKK 204,789. The solvency ratio was 97.2%.
- Gross Profit
- DKK -19,827
- Profit/Loss
- DKK -15,465
- Equity
- DKK 204,789
- Total Assets
- DKK 210,789
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -20 t. | -15 t. | 205 t. | - |
| 2018 | - | -39 t. | -31 t. | 20 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
EnteroTarget ApS has published its annual report for 2018. Gross profit came to DKK -39,418, and the net result was DKK -30,746.
As of April 8, 2019, REVISORKOMPAGNIET GODKENDT REVISIONSANPARTSSELSKAB has been appointed auditor of EnteroTarget ApS.
About EnteroTarget ApS
EnteroTarget ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jørgen Olsen. The board consists of Jesper Thorvald Troelsen (chair), Jørgen Olsen, Mohammad Taha Yassin and Sebastien Olivier Marie Pratt. The company's owners include Stig Henning Møller Nielsen, NEO Anderson Holding ApS and TroePaz Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -743,935 and a net result of DKK -451,011 compared with DKK -257,942 the year before. Equity in the 2025 report amounted to DKK 4,079,894.